Study of Daclizumab in Patients With Chronic, Persistent Asthma

NCT00028288 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Facet Biotech